On the first day of the conference, Xialong Li, PhD and Jae Yoo, PhD discussed the history of 3D printing in the pharmaceutical industry and applications that they are researching or currently using in drug development.

 .

Li is CSO of Triastek and a professor/associate dean at the University of the Pacific. Yoo is chief technology officer of Aprecia Pharmaceuticals. These experts guided discussion of advances in 3D printing technology and applications in the biosciences.

 .

3D printing for the pharmaceutical industry 3D printing has been around since the 1980’s, however it’s first application for the pharmaceutical industry did not occur until 1996. This technology was developed by Michael Cima at the Massachusetts Institutes of Technology (MIT). After this, advances were slow due to the difficulty in optimizing the equipment for use with biologics, which remains a struggle today. There are several varieties of 3D printing machines, all with positives and […]

Click here to view original web page at www.scienceboard.net